WO2023046135 - POLYCYCLIC FUSED RING DERIVATIVES AND USE THEREOF
National phase entry:
Publication Number
WO/2023/046135
Publication Date
30.03.2023
International Application No.
PCT/CN2022/121202
International Filing Date
26.09.2022
Title **
[English]
POLYCYCLIC FUSED RING DERIVATIVES AND USE THEREOF
[French]
DÉRIVÉS DE CYCLES CONDENSÉS POLYCYCLIQUES ET LEUR UTILISATION
Applicants **
JACOBIO PHARMACEUTICALS CO., LTD.
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
Inventors
YANG, Hongwei
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
MA, Cunbo
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
GAO, Panliang
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
HAN, Huifeng
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
WANG, Peng
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
LI, Runze
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
ZHANG, Wei
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
LIU, Xiaoyu
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
WANG, Yanping
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
LONG, Wei
Building 8, No. 105 Jinghai 3rd Road, Business Development Area, Tongzhou District
Beijing 100176, CN
Priority Data
PCT/CN2021/120863
27.09.2021
CN
PCT/CN2022/081601
18.03.2022
CN
PCT/CN2022/102280
29.06.2022
CN
PCT/CN2022/120205
21.09.2022
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
CNIPA
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2608 | |
| EPO | Filing, Examination | 19485 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 673 | |
| USA | Filing, Examination | 10510 |
Total: 33867 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Provided are K-Ras mutant protein inhibitors of formula (I), a composition containing the same and the use thereof.[French]
L'invention concerne des inhibiteurs de protéine mutante K-Ras de formule (I), une composition les contenant et leur utilisation.